Lebrikizumab Dosed Every Four Weeks Maintained Durable Skin Clearance in Lilly's Phase 3 Monotherapy Atopic Dermatitis Trials
New, late-breaking data show lebrikizumab responders reported long-lasting results at one year of treatment across measures of improvement in skin clearance, itch and disease extent and severity
Results suggest less frequent, every four week... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 8, 2022 Category: Pharmaceuticals Source Type: clinical trials
Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)
Conditions: Scabies; Itch; Scabies Intervention: Drug: Ivermectin Tablets Sponsors: Murdoch Childrens Research Institute; Burnet Institute; Lao Tropical and Public Health Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2022 Category: Research Source Type: clinical trials